All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Artizan Biosciences Inc. has kept a low profile since its creation in 2016, quietly raising money and forging a path to finding a cure for certain diseases involving human intestinal microbiota. It stepped out Monday when it announced completion of a series A funding round totaling $12 million.